BioSpace News Archive

Former Chairman and CEO George Messina named Chairman Emeritus; appointed President and Chief Executive Officer of NorthStar Nuclear Therapies LLC

Quaker Heights Care Community in Waynesville, Ohio has joined Ohio Living as its 13th community.

Pomerantz LLP is investigating claims on behalf of investors of OPKO Health

Pitch competition wrapped up CBSA’s Colorado Life Science Innovation Forum

Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announced that it has met the requirements within its existing loan and security agreement with Silicon Valley Bank (“SVB”) to extend the interest only periods between September 30, 2018 and March 31, 2019.

BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of two United States patents.

Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million.

Warriors and their families toured the Springfield Armory National Historic Site during a recent Wounded Warrior Project® (WWP) outing. This armory consistently supplied our armed forces from 1794 until 1964.

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, has been named the Trailblazer 2018 Company of the Year in the Medical Device/Diagnostics Category by PM360, a respected publication for marketing decision-makers in the pharmaceutical, biotech and medical device industries.

IV Drips, a US-based company that specializes in intravenous hydration and wellness, embarked on a marketing campaign where it sought to promote the benefits of IV therapy.